skip to content
Primary navigation


DrugSilenor (doxepin) [Somaxon]

July 2011

Therapeutic Area - Insomnia

FDA approved indication

Indicated for the treatment of insomnia characterized by difficulties with sleep maintenance.


  • Patient has been diagnosed with insomnia AND
  • Patient has failed zolpidem by ineffectiveness or intolerance AND
  • Patient has been tried on doxepin liquid formulation (10mg/mL) and has shown therapeutic benefit AND
  • Prescriber provides clinical rationale why doxepin liquid formulation cannot continue to be used


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top